Nevertheless, it was also reported that blockage of TNF overcome the resistance to anti-PD-1 treatment in experimental melanoma (44), and the treatment with TNF inhibitors enhanced the anti-tumor effect of combined CTLA-4 and PD-1 immunotherapy (45). The gene discussed is CTLA4; the disease is melanoma.